4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer C Seidel, M Schnekenburger, A Mazumder, MH Teiten, G Kirsch, M Dicato, ... Biochemical pharmacology 99, 31-52, 2016 | 101 | 2016 |
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in … C Florean, M Schnekenburger, JY Lee, KR Kim, A Mazumder, S Song, ... Oncotarget 7 (17), 24027, 2016 | 66 | 2016 |
Natural scaffolds in anticancer therapy and precision medicine A Mazumder, C Cerella, M Diederich Biotechnology advances 36 (6), 1563-1585, 2018 | 48 | 2018 |
Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A De Carvalho, ... Frontiers in pharmacology 9, 70, 2018 | 42 | 2018 |
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ... Cancer letters 438, 197-218, 2018 | 33 | 2018 |
Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia C Cerella, A Gaigneaux, A Mazumder, JY Lee, E Saland, F Radogna, ... Leukemia 31 (3), 755-759, 2017 | 33 | 2017 |
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia S Song, JY Lee, L Ermolenko, A Mazumder, S Ji, H Ryu, HJ Kim, DW Kim, ... Cell death & disease 11 (2), 109, 2020 | 32 | 2020 |
Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New … M Schnekenburger, E Goffin, JY Lee, JY Jang, A Mazumder, S Ji, ... Journal of medicinal chemistry 60 (11), 4714-4733, 2017 | 27 | 2017 |
HER2 activation and endocrine treatment resistance in HER2-negative breast cancer A Mazumder, S Shiao, S Haricharan Endocrinology 162 (10), bqab153, 2021 | 25 | 2021 |
The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer S Ji, JY Lee, J Schrör, A Mazumder, DM Jang, S Chateauvieux, ... Cancer letters 416, 109-123, 2018 | 25 | 2018 |
Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer EY Efe, A Mazumder, JY Lee, A Gaigneaux, F Radogna, MJ Nasim, ... Cancer Letters 410, 139-157, 2017 | 25 | 2017 |
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells M Lernoux, M Schnekenburger, H Losson, K Vermeulen, H Hahn, ... Clinical Epigenetics 12, 1-26, 2020 | 22 | 2020 |
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ... Nature communications 12 (1), 2940, 2021 | 20 | 2021 |
The DNA damage repair landscape in Black women with breast cancer A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ... Therapeutic advances in medical oncology 14, 17588359221075458, 2022 | 17 | 2022 |
Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells C Grandjenette, M Schnekenburger, A Gaigneaux, D Gerard, C Christov, ... Cancer Letters 469, 468-480, 2020 | 13 | 2020 |
Preclinical assessment of the bioactivity of the anticancer coumarin OT48 by spheroids, colony formation assays, and zebrafish xenografts JY Lee, A Mazumder, M Diederich Journal of visualized experiments: JoVE, 57490, 2018 | 11 | 2018 |
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia H Losson, SR Gajulapalli, M Lernoux, JY Lee, A Mazumder, D Gérard, ... Pharmacological Research 160, 105058, 2020 | 10 | 2020 |
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness E Oropeza, S Seker, S Carrel, A Mazumder, D Lozano, A Jimenez, ... Science Advances 9 (26), eadf2860, 2023 | 9 | 2023 |
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome MN Bainbridge, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ... Brain 145 (10), 3383-3390, 2022 | 8 | 2022 |
Discovery and characterization of M Schnekenburger, E Goffin, JY Lee, JY Jang, A Mazumder, S Ji, ... R/S-N, 0 | 5 | |